European Journal of Pharmaceutical Sciences 1 March 2025

Title	European Journal of Pharmaceutical Sciences 1 March 2025
Edition	1 March 2025
Call Number
ISBN/ISSN
Author(s)
Subject(s)	drug delivery Triple-negative breast cancer (TNBC) apoptosis
Classification
Series Title
GMD	Jurnal
Language	Indonesia
Publisher
Publishing Year	2025
Publishing Place
Collation
Abstract/Notes	ABSTRACT Triple-negative breast cancer (TNBC) presents with resistance phenotypes to certain therapies, such as cisplatin, often requiring higher dosing, with associated acquired tumor resistance, renal toxicity, and variable patient responses. A self-emulsifying drug delivery (SEDD) formulation approach was proposed to overcome the limi- tations of cisplatin in TNBC, focusing on improving intracellular cisplatin and control siRNA uptake as a proof-of- principle of dual drug delivery. Four SEDD formulations were prepared and optimized for cisplatin (o/w) emulsion and FITC-siRNA (w/o) emulsion using pseudo-ternary phase diagrams to facilitate the formation of water-in-oil-water (w/o/w) emulsions. Formulations were characterized by size, polydispersity (PDI), and sur- face charge and tested in vitro. Cellular uptake via triplex staining of drug-loaded SEDDs was investigated. SEDDs showed enhanced internalization and promoted selective TNBC cellular uptake. The current study is a proof-of- principle for the successful co-delivery of cisplatin (small molecule) and siRNA (large molecule) via the SEDDs platform.
Specific Detail Info
Image
File Attachment	LOADING LIST...
Availability	LOADING LIST...
	Back To Previous